Stock 6797 TAIWAN ADVANCED NANOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Taiwan Advanced Nanotech Inc.

Equities

6797

TW0006797004

Advanced Medical Equipment & Technology

End-of-day quote Taipei Exchange
Other stock markets
 18:00:00 2024-06-30 EDT 		5-day change 1st Jan Change
29.45 TWD +0.86% Intraday chart for Taiwan Advanced Nanotech Inc. +5.37% -24.49%
04-30 Taiwan Advanced Nanotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Taiwan Advanced Nanotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2020 2021 2022 2023
Capitalization 1 5,351 2,861 1,766 1,189
Enterprise Value (EV) 1 4,890 2,397 1,070 877.3
P/E ratio 8.33 x 4.82 x 5.56 x -5.71 x
Yield 5.53% 4.86% 5.11% -
Capitalization / Revenue 3.11 x 1.48 x 1.33 x 4.84 x
EV / Revenue 2.84 x 1.24 x 0.81 x 3.57 x
EV / EBITDA 5.89 x 2.85 x 2.63 x -4.65 x
EV / FCF 10.6 x 7.44 x 4.78 x -2.92 x
FCF Yield 9.41% 13.4% 20.9% -34.3%
Price to Book 5.64 x 2.24 x 1.21 x 1 x
Nbr of stocks (in thousands) 30,246 30,120 30,093 30,480
Reference price 2 176.9 95.00 58.70 39.00
Announcement Date 4/19/21 3/31/22 3/17/23 4/30/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 101.9 114 1,719 1,928 1,327 245.6
EBITDA 1 -19.28 -35.47 830.5 840.9 406.5 -188.8
EBIT 1 -28.56 -45.56 797.7 800.8 344 -261.4
Operating Margin -28.03% -39.98% 46.4% 41.53% 25.93% -106.42%
Earnings before Tax (EBT) 1 -27.1 -44.77 773.1 791.3 460.7 -243.5
Net income 1 -20.94 -36.6 618.2 626 326 -208.2
Net margin -20.56% -32.12% 35.96% 32.46% 24.58% -84.76%
EPS 2 -0.8951 -1.427 21.24 19.72 10.55 -6.830
Free Cash Flow 1 -1.08 -61.21 460.2 322.1 223.7 -300.6
FCF margin -1.06% -53.71% 26.77% 16.7% 16.86% -122.4%
FCF Conversion (EBITDA) - - 55.41% 38.31% 55.02% -
FCF Conversion (Net income) - - 74.44% 51.45% 68.61% -
Dividend per Share - - 9.790 4.615 3.000 -
Announcement Date 8/18/20 8/18/20 4/19/21 3/31/22 3/17/23 4/30/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 105 5.27 462 465 697 311
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -1.08 -61.2 460 322 224 -301
ROE (net income / shareholders' equity) -13.9% -22.1% 113% 56.3% 25.6% -17.6%
ROA (Net income/ Total Assets) -9.64% -12.5% 47.1% 24.5% 9.49% -7.93%
Assets 1 217.3 292.7 1,313 2,553 3,434 2,626
Book Value Per Share 2 7.160 5.740 31.30 42.30 48.70 38.90
Cash Flow per Share 2 4.040 2.830 22.00 12.30 23.40 14.10
Capex 1 2.62 11.6 127 175 45.3 51.5
Capex / Sales 2.57% 10.22% 7.39% 9.1% 3.41% 20.97%
Announcement Date 8/18/20 8/18/20 4/19/21 3/31/22 3/17/23 4/30/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
TAIWAN ADVANCED NANOTECH INC. Stock Taiwan Advanced Nanotech Inc.
-24.49% 27.54M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+2.06% 211B
DANAHER CORPORATION Stock Danaher Corporation
+5.69% 185B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+29.31% 158B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+2.36% 64.32B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+18.36% 55.66B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-1.92% 48.41B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-8.37% 37.82B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
-1.37% 35.57B
RESMED, INC. Stock ResMed, Inc.
+8.67% 28.12B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. 6797 Stock
  4. Financials Taiwan Advanced Nanotech Inc.